Summary：**Trump’s Abraham Accords Face Jeopardy as U.S. Distrust Plummets**The Abraham Accords, a set of bil

**Trump’s Abraham Accords Face Jeopardy as U.S. Distrust Plummets**The Abraham Accords, a set of bilateral agreements between the United States and Israel, have come under increasing scrutiny as American public trust in the administration has plummeted. Announced during Trump’s presidency, these accords aim to normalize relations with Israel, paving the way for a potential peaceful resolution of the long-standing Middle East conflict. However, as U.S. relations with Israel deepen, so too does the risk that these accords could bejeopardized by changing geopolitical dynamics and shifting administration priorities.**Key Developments**The Abraham Accords were formally signed in September 2017, following a period of intense diplomatic efforts under Trump’s leadership. These agreements include measures that grant Israel immunity from international laws on cyberattacks, allow for joint military exercises, and pave the way for indirect dialogue between Palestinian Authority and Israel. In theory, this framework seeks to bypass the decades-long conflict with Syria while maintaining U.S. influence in the region.However, the sudden shift in U.S. foreign policy priorities has raised concerns among both allies and adversaries. Recent developments suggest a greater emphasis on domestic security and a diminishing role for the U.S. in Middle East affairs. This pivot may have left key elements of the Abraham Accords vulnerable to reinterpretation or repeal by incoming administrations.**Industry Analysis**The defense contracting industry, which heavily relies on U.S.-Israel ties, is particularly concerned about the potential impact on its operations. Key players such as Raytheon, Northrop Grumman, andLockheed Martin are monitoring developments closely, as their contracts with Israeli firms could be affected if the Abraham Accords are altered or repealed.On the pharmaceutical side, several companies have expressed worries that any changes in U.S. policy toward Israel could lead to delays in procuring critical medical supplies for U.S. allies in the region. The reliance on indirect dialogue between Israel and Palestinian Authority also raises questions about the long-term sustainability of these accords.**Future Outlook**The incoming Biden administration has signaled a willingness to re-examine its predecessor’s policies, particularly those that have drawn criticism from domestic and international audiences. While there is no indication that the Abraham Accords will be reversed outright, the new administration may seek to impose additional restrictions on U.S.-Israel ties in order to align with broader foreign policy goals.The potential for further developments remains uncertain, but signs suggest heightened competition among regional powers to maintain influence over Israel’s affairs. This dynamic could create opportunities for cooperation or conflict, depending on how the Biden administration navigates its relationship with both the Trump administration and Israeli leaders.**Conclusion**The Abraham Accords represent a significant moment in U.S.-Israel relations, offering a rare opportunity to de-escalate tensions in the region. Yet, as public trust continues to erode, even this fragile framework remains at risk of being disrupted. The future of these accords will depend not only on the willingness of both sides to maintain their commitments but also on how they adapt to shifting geopolitical realities. As U.S. leaders seek to balance national security interests with regional responsibilities, the Abraham Accords may find themselves testifying to a time when diplomacy and foreign policy were still deeply intertwined.